The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases

The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases

Spleen tyrosine kinase (SYK) is an enigmatic protein tyrosine kinase, and involved in signal transduction related with lots of cellular processes. It’s highly expressed in the cells of hematopoietic origin and acts as an important therapeutic target in the treatment of autoimmune diseases and allerg...

Полное описание

Библиографические подробности
Главные авторы:	Yaping Zhao, Rongrong Liu, Miaomiao Li, Pengfei Liu
Формат:	Статья
Язык:	English
Опубликовано:	Elsevier 2022-12-01
Серии:	Heliyon
Предметы:	Spleen tyrosine kinase (SYK) Liver diseases Small molecule inhibitor Therapy target
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2405844022034181

Схожие документы

The selective inhibition of the Syk tyrosine kinase ameliorates experimental autoimmune arthritis
по: Eszter Káposztás, и др.
Опубликовано: (2023-12-01)

Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib
по: Nichola Cooper, и др.
Опубликовано: (2023-01-01)

Biochemical characterization of spleen tyrosine kinase (SYK) isoforms in platelets
по: Pankaj Kumar Singh, и др.
Опубликовано: (2023-12-01)

Activation of spleen tyrosine kinase (SYK) contributes to neuronal pyroptosis and cognitive impairment in diabetic mice via the NLRP3/Caspase-1/GSDMD signaling pathway
по: Chenglong Zhou, и др.
Опубликовано: (2024-12-01)

Identification of high-performing antibodies for tyrosine-protein kinase SYK for use in Western Blot, immunoprecipitation and immunofluorescence [version 3; peer review: 2 approved]
по: Carl Laflamme, и др.
Опубликовано: (2024-06-01)

Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice
по: Dániel Csete, и др.
Опубликовано: (2019-04-01)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
по: Mohan Li, и др.
Опубликовано: (2023-05-01)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
по: Ryunosuke Muro, и др.
Опубликовано: (2023-01-01)

Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis
по: Christopher W. Pohlmeyer, и др.
Опубликовано: (2021-03-01)

Anti-microbial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinase
по: Bright Obeng, и др.
Опубликовано: (2024-12-01)

Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
по: Kata P. Szilveszter, и др.
Опубликовано: (2019-08-01)

S-Layer From Lactobacillus brevis Modulates Antigen-Presenting Cell Functions via the Mincle-Syk-Card9 Axis
по: Mariano Prado Acosta, и др.
Опубликовано: (2021-03-01)

A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells
по: Hyang‑Hee Seo, и др.

Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to <italic toggle="yes">Candida</italic> Species
по: Paige E. Negoro, и др.
Опубликовано: (2020-06-01)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
по: Yaqi Zhou, и др.
Опубликовано: (2023-07-01)

CCL4‐mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease
по: Wenbin Gong, и др.
Опубликовано: (2021-02-01)

Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma
по: Qian Liu, и др.
Опубликовано: (2022-05-01)

Systematic analysis of spleen tyrosine kinase expression and its clinical outcomes in various cancers
по: Akram I Alwithenani, и др.
Опубликовано: (2020-01-01)

Phosphorylation of (Ser 291) in the linker insert of Syk negatively regulates ITAM signaling in platelets
по: Carol Dangelmaier, и др.
Опубликовано: (2024-12-01)

The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
по: Jing Wang, и др.
Опубликовано: (2023-02-01)

Expression of variant isoforms of the tyrosine kinase SYK differentially regulates cervical cancer progression through PI3K/AKT pathway
по: Bingjie Lin, и др.
Опубликовано: (2024-11-01)

Three Novel Players: PTK2B, SYK, and TNFRSF21 Were Identified to Be Involved in the Regulation of Bovine Mastitis Susceptibility via GWAS and Post-transcriptional Analysis
по: Fan Yang, и др.
Опубликовано: (2019-08-01)

Development of SYK NanoBRET cellular target engagement assays for gain–of–function variants
по: Jacob L. Capener, и др.
Опубликовано: (2024-07-01)

Effects of a spleen tyrosine kinase inhibitor on progression of the lupus nephritis in mice
по: Maki Kitai, и др.
Опубликовано: (2017-05-01)

Mechanisms of acquired resistance to tyrosine kinase inhibitors
по: Yi-fan Chen, и др.
Опубликовано: (2011-12-01)

Tyrosine kinase targeting: A potential therapeutic strategy for diabetes
по: Mohammad Althubiti
Опубликовано: (2022-01-01)

Spleen tyrosine kinase inhibitors disrupt human neutrophil swarming and antifungal functions
по: Alex Hopke, и др.
Опубликовано: (2025-01-01)

Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease
по: Soumitra Ghosh, и др.
Опубликовано: (2015-11-01)

Fluorescent Tracking of Yeast Division Clarifies the Essential Role of Spleen Tyrosine Kinase in the Intracellular Control of Candida glabrata in Macrophages
по: Zeina Dagher, и др.
Опубликовано: (2018-05-01)

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
по: Chen-Yu Hu, и др.
Опубликовано: (2019-12-01)

Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
по: Xuejin Ou, и др.
Опубликовано: (2024-09-01)

Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization
по: Halil Ibrahim Onder, и др.
Опубликовано: (2014-04-01)

Receptor Tyrosine Kinase Signaling Involves <i>Echinococcus</i>–Host Intercommunication: A Potential Therapeutic Target in Hepatic Echinococcosis
по: Haijun Gao, и др.
Опубликовано: (2024-08-01)

Advances in studies of tyrosine kinase inhibitors and their acquired resistance
по: Qinlian Jiao, и др.
Опубликовано: (2018-02-01)

Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
по: Sareshma Sudhesh Dev, и др.
Опубликовано: (2021-11-01)

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
по: D. Samuel Metibemu, и др.
Опубликовано: (2019-12-01)

Recent developments in receptor tyrosine kinases targeted anticancer therapy
по: Samir H. Raval, и др.
Опубликовано: (2016-01-01)

Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin
по: Hadas Smadar, и др.
Опубликовано: (2012-07-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
по: Xu H, и др.
Опубликовано: (2019-07-01)

Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma
по: Ming Zeng, и др.
Опубликовано: (2024-03-01)